A Proteomic Analysis of Human Bile

de Groen, 1999, Biliary tract cancers., N. Engl. J. Med., 341, 1368, 10.1056/NEJM199910283411807 Gores, 2000, Early detection and treatment of cholangiocarcinoma., Liver Transpl., 6, S30, 10.1053/jlts.2000.18688 Mansfield, 1997, A prospective evaluation of cytology from biliary strictures., Gut, 40, 671, 10.1136/gut.40.5.671 Ponsioen, 1999, Value of brush cytology for dominant strictures in primary sclerosing cholangitis., Endoscopy, 31, 305, 10.1055/s-1999-18 Sturm, 1999, Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis., Clin. Cancer Res., 5, 629 Bjornsson, 1999, CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis., Liver, 19, 501, 10.1111/j.1478-3231.1999.tb00083.x Patel, 2000, The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis., Am. J. Gastroenterol., 95, 204, 10.1111/j.1572-0241.2000.01685.x Muller, 2001, Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: A prospective study in more than 100 patients., Eur J. Clin. Invest., 31, 240, 10.1046/j.1365-2362.2001.00800.x Srinivas, 2001, Proteomics in early detection of cancer., Clin. Chem., 47, 1901, 10.1093/clinchem/47.10.1901 Verma, 2001, Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers., Ann. N. Y. Acad. Sci., 945, 103, 10.1111/j.1749-6632.2001.tb03870.x Shevchenko, 1996, Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels., Anal. Chem., 68, 850, 10.1021/ac950914h Kuster, 1999, 18O-labeling of N-glycosylation sites to improve the identification of gel-separated glycoproteins using peptide mass mapping and database searching., Anal. Chem., 71, 1431, 10.1021/ac981012u Robertson, 1996, Glycoproteins: A consideration of the potential problems and their solutions with respect to purification and characterisation., Bioseparation, 6, 1 Charlwood, 2001, Analysis of N-linked oligosaccharides: Progress towards the characterisation of glycoprotein-linked carbohydrates., Biomol. Eng., 18, 229, 10.1016/S1389-0344(01)00098-3 Perkins, 1999, Probability-based protein identification by searching sequence databases using mass spectrometry data., Electrophoresis, 20, 3551, 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2 Anderson, 2002, The human plasma proteome: history, character, and diagnostic prospects., Mol. Cell. Proteomics, 1, 845, 10.1074/mcp.R200007-MCP200 Bhattacharyya, 1989, Interactions of concanavalin A with asparagine-linked glycopeptides. Structure/activity relationships of the binding and precipitation of oligomannose and bisected hybrid-type glycopeptides with concanavalin A., Eur. J. Biochem., 178, 721, 10.1111/j.1432-1033.1989.tb14503.x Kawashima, 1990, Carbohydrate binding specificities of several poly-N-acetyllactosamine-binding lectins., Glycoconj. J., 7, 323, 10.1007/BF01073376 Durand, 2000, Protein glycosylation and diseases: Blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring., Clin. Chem., 46, 795, 10.1093/clinchem/46.6.795 Liu, 1992, Deamidation: A source of microheterogeneity in pharmaceutical proteins., Trends Biotechnol., 10, 364, 10.1016/0167-7799(92)90269-2 Yuksel, 1986, In vitro deamidation of human triosephosphate isomerase., Arch. Biochem. Biophys, 248, 452, 10.1016/0003-9861(86)90498-4 Gonzalez, 1992, Anal. Biochem., 205, 151, 10.1016/0003-2697(92)90592-U Kaji, 2003, Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins., Nat. Biotechnol., 21, 667, 10.1038/nbt829 Hinoda, 1988, Molecular cloning of a cDNA coding biliary glycoprotein I: Primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen., Proc. Natl. Acad. Sci. U. S. A., 85, 6959, 10.1073/pnas.85.18.6959 Modugno, 2003, Ovarian cancer and high-risk women—Implications for prevention, screening, and early detection., Gynecol. Oncol., 91, 15, 10.1016/S0090-8258(03)00254-3 Haga, 1986, Clinical significance of serum CA125 values in patients with cancers of the digestive system., Am. J. Med. Sci., 292, 30, 10.1097/00000441-198607000-00006 Chen, 2002, The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma—The influence of sampling time and hepatolithiasis., Hepatogastroenterology, 49, 616 Ker, 1991, Assessment of serum and bile levels of CA19-9 and CA125 in cholangitis and bile duct carcinoma., J. Gastroenterol. Hepatol., 6, 505, 10.1111/j.1440-1746.1991.tb00896.x Brockmann, 2000, Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies., Anticancer Res., 20, 4941 Sasaki, 1995, Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucins during intrahepatic bile duct development and maturation. An immunohistochemical study., Am. J. Pathol., 147, 574 Sasaki, 1996, Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: An immunohistochemical study., Hepatology, 24, 1074, 10.1002/hep.510240516 Higashi, 1999, Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma., Hepatology, 30, 1347, 10.1002/hep.510300609 Koths, 1993, Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain., J. Biol. Chem., 268, 14245, 10.1016/S0021-9258(19)85233-X Inohara, 1996, Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion., Cancer Res., 56, 4530 Iacobelli, 1986, Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer., Cancer Res., 46, 3005 Marchetti, 2002, Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients., Cancer Res., 62, 2535 Fusco, 1998, 90K (MAC-2 BP) gene expression in breast cancer and evidence for the production of 90K by peripheral-blood mononuclear cells., Int. J. Cancer, 79, 23, 10.1002/(SICI)1097-0215(19980220)79:1<23::AID-IJC5>3.0.CO;2-Y Scambia, 1988, Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer., Anticancer Res., 8, 761 D’Ostilio, 1996, Prognostic value of a novel interferon-inducible 90K tumor antigen., Ann. N. Y. Acad. Sci., 784, 288, 10.1111/j.1749-6632.1996.tb16243.x Bratt, 2000, Lipocalins and cancer., Biochim. Biophys. Acta, 1482, 318, 10.1016/S0167-4838(00)00154-0 Stoesz, 1995, Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas., Oncogene, 11, 2233 Nielsen, 1996, Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases., Gut, 38, 414, 10.1136/gut.38.3.414 Stoesz, 1998, Heterogeneous expression of the lipocalin NGAL in primary breast cancers., Int. J. Cancer, 79, 565, 10.1002/(SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.0.CO;2-F Terris, 2002, Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas., Am. J. Pathol., 160, 1745, 10.1016/S0002-9440(10)61121-2 Furutani, 1998, Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method., Cancer Lett., 122, 209, 10.1016/S0304-3835(97)00391-1 Monier, 2000, Gelatinase isoforms in urine from bladder cancer patients., Clin. Chim. Acta, 299, 11, 10.1016/S0009-8981(00)00271-0 Mollenhauer, 1997, DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours., Nat. Genet., 17, 32, 10.1038/ng0997-32 Holmskov, 1999, Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D., Proc. Natl. Acad. Sci. U. S. A., 96, 10794, 10.1073/pnas.96.19.10794 Wu, 1999, Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer., Cancer Res., 59, 1846 Mori, 1999, Lack of DMBT1 expression in oesophageal, gastric and colon cancers., Br J Cancer, 79, 211, 10.1038/sj.bjc.6690035 Sasaki, 2002, Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines., Cancer Res., 62, 4894 He, 1997, Two-dimensional electrophoretic analysis of vesicular and micellar proteins of gallbladder bile., J. Chromatogr. A, 776, 109, 10.1016/S0021-9673(97)00560-8 Stark, 1999, Isolation and characterization of hydrophobic polypeptides in human bile., Eur. J. Biochem., 266, 209, 10.1046/j.1432-1327.1999.00845.x Jones, 2003, Proteomic characterization of metabolites, protein adducts, and biliary proteins in rats exposed to 1,1-dichloroethylene or diclofenac., Chem. Res. Toxicol., 16, 1306, 10.1021/tx0340807 Anderson, 2004, The human plasma proteome: A non-redundant list developed by combination of four separate sources., Mol. Cell. Proteomics, 3, 311, 10.1074/mcp.M300127-MCP200